FindTrial
Sign In

Surveillance of intestinal lesions in patients taking new oral anticoagulant drugs

Surveillance of intestinal lesions in patients taking new oral anticoagulant drugs - Intestinal lesions by new oral anticoagulant drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011527
Enrollment
50
Registered
2013-10-01
Start date
2013-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surveillance of intestinal lesions in patients taking new oral anticoagulant drugs

Interventions

capsule endoscopy

Sponsors

Saitama Medical School
Lead Sponsor
Keio University Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients taking new oral anticoagulant drugs

Exclusion criteria

Exclusion criteria: stenosis of GI tract

Design outcomes

Primary

MeasureTime frame
intestinal lesions—

Countries

Japan

Contacts

Public ContactHiroyuki Imaeda

Saitama Medical School Department of General Internal Medicine

imaedahi@saitama-med.ac.jp049-276-1667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026